Can axSpA progress to involve peripheral joints and vice versa, and what is the prevalence of this overlap?

The relationship between axSpA and pSpA manifestations is complex, with significant overlap and bidirectional progression.
Axial to peripheral progression: axSpA can develop peripheral manifestations over time, though this progression is less common than the reverse. Studies indicate that approximately 20-30% of patients with predominantly axSpA develop clinically significant peripheral arthritis during their disease course. Hip involvement is particularly common, affecting 25-30% of axSpA patients and is associated with more severe disease outcomes.
Peripheral to axial progression: pSpA can progress to involve axial structures, particularly the SI joints and spine. This progression is more common in certain subtypes, with ReA and IBD-associated arthritis showing higher rates of axial involvement development. Approximately 30-50% of patients with pSpA may develop axial symptoms over time, though not all progress to r-axSpA.
Overlap prevalence: Mixed axial and peripheral presentations are common, with studies showing that 40-60% of SpA patients have both axial and peripheral features at some point during their disease course. This overlap is particularly frequent in PsA, where axial involvement occurs in 25-70% of patients depending on the criteria used and study population.
Risk factors for progression: Several factors influence the likelihood of progression between axial and peripheral disease. HLA-B27 positivity is associated with higher rates of axial involvement in patients with pSpA. Male gender, younger age of onset, and family history of SpA are also associated with increased risk of axial progression. The presence of enthesitis in pSpA patients may predict future axial involvement.
REFERENCE
1. Ediboglu ED, Kalyoncu U, Solmaz D, Bilge SY, Yılmaz S, Bes C, et al. Predicting extra- musculoskeletal and peripheral manifestations and their role on biologic treatment in patients with axial spondyloarthritis: TReasure experience. Arch Rheumatol. 2025;40(1):001–14.
2. Benavent D, Plasencia-Rodríguez C, Franco-Gómez K, Nieto R, Monjo-Henry I, Peiteado D, Balsa A, Navarro-Compán V. Axial spondyloarthritis and axial psoriatic arthritis: similar or different disease spectrum? Ther Adv Musculoskelet Dis. 2020 Nov 16;12:1759720X20971889.